MedTrace Logo

Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis

NCT02749656 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2017-05-01

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy and safety of 0.25% Desoximetasone cream (Topoxy®) compare with 0.25% Desoximetasone cream (Topicorte®) in the treatment of scalp psoriasis.

Conditions

  • Scalp Psoriasis

Interventions

DRUG

0.25% Desoximetasone cream (Topoxy®)

apply on the scalp psoriasis lesion twice a day

DRUG

0.25% Desoximetasone cream (Topicorte®)

apply on the scalp psoriasis lesion twice a day

DRUG

Placebo

apply on the scalp psoriasis lesion twice a day

Sponsors & Collaborators

  • SPS MEDICAL CO.,LTD.

    collaborator UNKNOWN

  • Siriraj clinical research center

    collaborator UNKNOWN

  • Siriraj Hospital

    lead OTHER

Principal Investigators

  • Associated. Prof. Chanisada Wongpraparut, M.D. · Mahidol University

  • Assist. Prof. Leena Chularojmontri, M.D. · Mahidol University

  • Assist. Prof. Narumol Silpa-archa, M.D. · Mahidol University

  • Pichanee Chaweekulrat, M.D. · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-01-31
Completion
2018-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02749656 on ClinicalTrials.gov